Abstract
An objective approach to the surgical palliation of pleural, pulmonary, and mediastinal malignancy with a focus on minimally invasive, low-morbidity techniques
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wildgaard K, Ravn J, Kehlet H. Chronic post-thoracotomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiothorac Surg. 2009;36(1):170–80.
Heffner JE. Diagnosis and management of malignant pleural effusions. Respirology. 2008;13:5–20.
Bernard A, de Dompsure RB, Hagry O, et al. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg. 2002;74:213–7.
Dresler CM, Olak J, Herndon II JE, et al. Phase III intergroup study of talc poudrage vs. talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127:909–15.
Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg. 2006;30(6):827–32.
Lee P. Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes. Chest. 2012;142(1):15–7.
Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56–64.
Tan C, Sedrakyan A, Browne J, et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. 2006;29:829–38.
Colt HG, Davoudi M. The ideal pleurodesis agent: still searching after all these years. Lancet Oncol. 2008;9:912–3.
Efthymiou CA, Masudi T, Thorpe JA, Papagiannopoulos K. Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunneled catheters. Interact Cardiovasc Thorac Surg. 2009;9(6):961–4.
Fysh ET, Waterer GW, Kendall P, Bremner P, Dina S, Geelhoed E, et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012;142(2):394–400.
Davies H, Mishra E, Wrightson J, Stanton A. The second therapeutic intervention in Malignant Effusion Trial (TIME2): a randomized controlled trial to assess the efficacy and safety of patient controlled malignant pleural effusion by indwelling pleural catheter compared to chest tube and Talc Slurry. Am J Respir Crit Care Med. 2012;185:6860.
Tsao AS, Witsuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol. 2009;27:2081–90.
Kaufman AJ, Flores RM. Surgical treatment of malignant pleural mesothelioma. Curr Treat Options Oncol. 2011;12:201–16.
Kindler HL. Surgery for mesothelioma? The debate continues. Lancet Oncol. 2011;12:713–4.
Rice D. Surgical therapy of mesothelioma. Recent results. Cancer Res. 2011;189:97–125.
Maziak DE, Gagliardi A, Haynes AE, et al. Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary. Lung Cancer. 2005;48:157–69.
Rice D, Rusch V, Passh H, et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. J Thorac Oncol. 2011;6:1304–12.
Tsao S, Witsuba I, Hasani A, Alvarez JM, Wyatt JM, et al. Outcome for patients with malignant pleural mesothelioma referred for tri-modality therapy in Western Australia. J Thorac Oncol. 2009;4:1110–6.
Thomford N, Woolner L, Clagett O. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357–63.
Roth J, Pass H, Wesley M, White D, Putnam I. Comparison of median sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft-tissue sarcomas. Ann Thorac Surg. 1986;42:134–8.
Vogt-Moykopf I, Krysa S, Bülzebruck H, Schirren J. Surgery for pulmonary metastases. The Heidelberg experience. Chest Surg Clin N Am. 1994;4:85–112.
Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol. 2010;5(6 Suppl 2):S172–8.
Neeff H, Hörth W, Makowiec F, Fischer E. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009;13:1813–20.
Meimarakis G, Angele M, Schneider C, Weidenhagen R, Kalaitzis N, Molki A, et al. Bedeutung der systematischen Lymphknoten-dissektion im Rahmen der Resektion pulmonaler Metastasen solider extrapulmonaler Tumoren. Zentralbl Chir. 2010;135:556–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jurisevic, C.A. (2014). Pleura, Chest Wall, Lung, and Mediastinum. In: Wichmann, M., Maddern, G. (eds) Palliative Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-53709-7_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-53709-7_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-53708-0
Online ISBN: 978-3-642-53709-7
eBook Packages: MedicineMedicine (R0)